Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Most Accessed Articles
Cancer Stem Cells in Prostate Cancer Chemoresistance
, 2014; 14(3): 225-240.Jie Ni, Paul Cozzi, Jingli Hao, Wei Duan, Peter Graham, John Kearsley and Yong Li
DOI: 10.2174/1568009614666140328152459
Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
, 2015; 15(2): 88-98.Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu
DOI: 10.2174/1568009615666150126154151
Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function
, 2010; 10(2): 155-167.A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer
DOI: 10.2174/156800910791054239
Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
, 2012; 12(1): 14-22.H. Miyamoto, Y. Zheng and K. Izumi
DOI: 10.2174/156800912798888965
Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review
, 2020; 20(9): 720-727.Jianguo Qiu, Wei Tang and Chengyou Du*
DOI: 10.2174/1568009620666200520084415
Immune Checkpoint Inhibitors in AML-A New Frontier
, 2020; 20(7): 545-557.Rohit Thummalapalli, Hanna A. Knaus, Ivana Gojo and Joshua F. Zeidner*
DOI: 10.2174/1568009620666200421081455
FLT3 Inhibition in Acute Myeloid Leukaemia – Current Knowledge and Future Prospects
, 2020; 20(7): 513-531.Francesca L. Hogan, Victoria Williams and Steven Knapper*
DOI: 10.2174/1570163817666200518075820
Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells
, 2012; 12(1): 74-84.Y.-W. Zhang, D.-L. Yan, W. Wang, H.-W. Zhao, X. Lu, J.-Z. Wu and J.-R. Zhou
DOI: 10.2174/156800912798888974
Stat3 Orchestrates Tumor Development and Progression: The Achilles Heel of Head and Neck Cancers?
, 2010; 10(1): 117-126.M. Masuda, T. Wakasaki, M. Suzui, S. Toh, A. K. Joe and I. B. Weinstein
DOI: 10.2174/156800910790980197
COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide
, 2020; 20(6): 410-416.Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net